» Articles » PMID: 22997553

Nitric Oxide Rescues Thalidomide Mediated Teratogenicity

Overview
Journal Sci Rep
Specialty Science
Date 2012 Sep 22
PMID 22997553
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Thalidomide, a sedative drug given to pregnant women, unfortunately caused limb deformities in thousands of babies. Recently the drug was revived because of its therapeutic potential; however the search is still ongoing for an antidote against thalidomide induced limb deformities. In the current study we found that nitric oxide (NO) rescues thalidomide affected chick (Gallus gallus) and zebrafish (Danio rerio) embryos. This study confirms that NO reduced the number of thalidomide mediated limb deformities by 94% and 80% in chick and zebrafish embryos respectively. NO prevents limb deformities by promoting angiogenesis, reducing oxidative stress and inactivating caspase-3 dependent apoptosis. We conclude that NO secures angiogenesis in the thalidomide treated embryos to protect them from deformities.

Citing Articles

Toxicokinetics of a developmental toxicity test in zebrafish embryos and larvae: Relationship with drug exposure in humans and other mammals.

Nawaji T, Mizoguchi N, Adachi R, Teraoka H Curr Res Toxicol. 2024; 7:100187.

PMID: 39104612 PMC: 11298605. DOI: 10.1016/j.crtox.2024.100187.


Thalidomide upper limb embryopathy - pathogenesis, past and present management and future considerations.

Vargesson N, Hooper G, Giddins G, Hunter A, Stirling P, Lam W J Hand Surg Eur Vol. 2023; 48(8):699-709.

PMID: 37226469 PMC: 10466950. DOI: 10.1177/17531934231177425.


Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish.

Dong W, Akasaka I, Komiyama A, Nakamura T, Mizoguchi N, Nawaji T Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986467 PMC: 10055635. DOI: 10.3390/ph16030368.


Nitric oxide mitigates thalidomide-induced abnormalities during germination and development of fennel seeds.

Swaminathan A, Kalyani K, Sudhagar S, Bhuvaneswari S, Nagalatha S, Raj T Toxicol Res (Camb). 2021; 10(4):893-901.

PMID: 34484681 PMC: 8403600. DOI: 10.1093/toxres/tfab071.


From the Farm to the Lab: How Chicken Embryos Contribute to the Field of Teratology.

Wachholz G, Rengel B, Vargesson N, Fraga L Front Genet. 2021; 12:666726.

PMID: 34367238 PMC: 8339958. DOI: 10.3389/fgene.2021.666726.


References
1.
Dimmeler S, Haendeler J, Nehls M, Zeiher A . Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med. 1997; 185(4):601-7. PMC: 2196141. DOI: 10.1084/jem.185.4.601. View

2.
Tweedie D, Frankola K, Luo W, Li Y, Greig N . Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation. Open Biochem J. 2011; 5:37-44. PMC: 3141331. DOI: 10.2174/1874091X01105010037. View

3.
Rafiee P, Stein D, Nelson V, Otterson M, Shaker R, Binion D . Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol. 2009; 298(2):G167-76. PMC: 2822501. DOI: 10.1152/ajpgi.00385.2009. View

4.
Noman A, Koide N, Khuda I, Dagvadorj J, Tumurkhuu G, Naiki Y . Thalidomide inhibits lipopolysaccharide-induced nitric oxide production and prevents lipopolysaccharide-mediated lethality in mice. FEMS Immunol Med Microbiol. 2009; 56(3):204-11. DOI: 10.1111/j.1574-695X.2009.00567.x. View

5.
Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C . Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998; 101(11):2567-78. PMC: 508846. DOI: 10.1172/JCI1560. View